Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial

Journal: Cancer Cell

Published: 2018-05-14

DOI: 10.1016/j.ccell.2018.04.004

Affiliations: 31

Authors: 30

Go to article
Institutions FC
Nottingham University Hospitals NHS Trust (NUH), United Kingdom (UK) 0.10
ICR Division of Molecular Pathology, United Kingdom (UK) 0.08
ICR Division of Cancer Therapeutics, United Kingdom (UK) 0.08
Hopp Children's Tumor Center at NCT Heidelberg (KiTZ), Germany 0.07
Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, France 0.07
Genentech, Inc., United States of America (USA) 0.07
F. Hoffmann-La Roche Ltd., Switzerland 0.07
Center for Data-Drive Discovery in Biomedicine (D3b), CHOP, United States of America (USA) 0.04
IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy 0.03
Roche Translational and Clinical Research Center (TCRC), United States of America (USA) 0.03
Comprehensive Cancer Center Vienna (CCC), Austria 0.03
Institute of Neuropathology, Uni Bonn, Germany 0.03
VU University Medical Center (VUmc), Netherlands 0.03
La Timone Institute of Neurosciences (INT), France 0.03
IRCCS Istituto Giannina Gaslini, Italy 0.03
Division of Neurosurgery, CHOP, United States of America (USA) 0.03
Division of Oncology, CHOP, United States of America (USA) 0.03
Great Ormond Street Hospital for Children (GOSH), United Kingdom (UK) 0.02
UCL Great Ormond Street Institute of Child Health (ICH), United Kingdom (UK) 0.02
IRCCS Istituto Neurologico Mediterraneo (IRCCS Neuromed), Italy 0.02
Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Italy 0.02
Hospital Sainte-Anne, France 0.02
Paris Descartes University (Paris 5), France 0.02
Berlin Institute of Health (BIH), Germany 0.01
Department of Neuropathology, Uni Heidelberg, Germany 0.01
German Consortium of Translational Cancer Research (DKTK), Germany 0.01